isoniazid has been researched along with levodopa in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (35.29) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Romankiewicz, JA | 1 |
Atkinson, AR; Norris, KA; Smith, WG | 1 |
Klerman, GL; Krauthammer, C | 1 |
Burton, K | 1 |
Gershanik, OS; Luquin, MR; Obeso, JA; Scipioni, O | 1 |
Morgan, JP | 1 |
O'Connell, MT; Patsalos, PN; Quinn, NP; Wenning, GK | 1 |
Oladeji, O; Padovani, A; Palvarini, L; Pezzini, A; Viale, P; Zavarise, P | 1 |
Ohki, M; Tayama, N | 1 |
McCauley, DW | 1 |
17 other study(ies) available for isoniazid and levodopa
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
Colorimetric enzymatic determination of serum total carbon dioxide, as applied to the Vickers Multichannel 300 discrete analyzer.
Topics: Acetoacetates; Aminosalicylic Acids; Animals; Ascorbic Acid; Autoanalysis; Bilirubin; Carbon Dioxide; Carboxy-Lyases; Edible Grain; Humans; Hydrogen-Ion Concentration; Isoniazid; Levodopa; Malate Dehydrogenase; Methyldopa; Myocardium; Oxaloacetates; Phosphoenolpyruvate; Pyruvates; Sulfathiazoles; Swine | 1975 |
Secondary mania: manic syndromes associated with antecedent physical illness or drugs.
Topics: Adrenal Cortex Hormones; Adult; Bipolar Disorder; Bromides; Epilepsy, Temporal Lobe; Humans; Isoniazid; Levodopa; Middle Aged; Neoplasms; Neurocognitive Disorders; Postoperative Complications; Procarbazine; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Renal Dialysis | 1978 |
The treatment of tremor.
Topics: Adrenergic beta-Antagonists; Alcoholic Beverages; Cerebellar Diseases; Humans; Isoniazid; Levodopa; Parkinson Disease; Primidone; Pyridoxine; Tremor | 1987 |
Isoniazid therapy in Parkinson's disease.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Isoniazid; Levodopa; Male; Middle Aged; Parkinson Disease | 1988 |
Isoniazid and levodopa.
Topics: Drug Interactions; Humans; Isoniazid; Levodopa; Male; Monoamine Oxidase | 1980 |
A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antitubercular Agents; Dopa Decarboxylase; Homovanillic Acid; Humans; Isoniazid; Levodopa; Male; Middle Aged; Parkinson Disease; Rifampin; Tuberculosis, Pulmonary | 1995 |
Holmes' tremor following midbrain Toxoplasma abscess: clinical features and treatment of a case.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Humans; Isoniazid; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral; Tremor | 2002 |
Dysphagia due to isoniazid therapy for tuberculosis in a patient with Lewy body dementia.
Topics: Aged; Antitubercular Agents; Deglutition Disorders; Dopamine Agents; Drug Interactions; Endoscopy; Female; Fluoroscopy; Humans; Isoniazid; Levodopa; Lewy Body Disease; Tuberculosis, Pleural; Video Recording | 2013 |
Serotonin plays an early role in the metamorphosis of the hydrozoan Phialidium gregarium.
Topics: Animals; Calcium; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Hydra; Levodopa; Metamorphosis, Biological; Models, Biological; Norepinephrine; Oligopeptides; Phorbol Esters; Protein Kinase C; Serotonin | 1997 |